Maki Iizuka
- Biochemistry top 5%
- Phytochemicals and Antioxidant Activities 3
- Antioxidant Activity and Oxidative Stress 3
-
- Cancer, Lipids, and Metabolism 5
- Nutrition and Dietetics top 10%
-
- Cholesterol and Lipid Metabolism 10
- Lipoproteins and Cardiovascular Health 2
-
- Peroxisome Proliferator-Activated Receptors 5
-
- Drug Transport and Resistance Mechanisms 3
-
- Blood Pressure and Hypertension Studies 2
Maki Iizuka
18 papers receiving 724 citations
Peers
Comparison fields: 5 of 93
- Biochemistry 123
- Endocrinology, Diabetes and Metabolism 157
- Cancer Research 107
- Nutrition and Dietetics 99
- Surgery 256
Countries citing papers authored by Maki Iizuka
This map shows the geographic impact of Maki Iizuka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maki Iizuka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maki Iizuka more than expected).
Fields of papers citing papers by Maki Iizuka
This network shows the impact of papers produced by Maki Iizuka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maki Iizuka. The network helps show where Maki Iizuka may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Maki Iizuka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 22 | |
| 2 | 2014 | 25 | |
| 3 | 2013 | 11 | |
| 4 | 2013 | 4 | |
| 5 | 2013 | 107 | |
| 6 | 2013 | 0 | |
| 7 | 2012 | 48 | |
| 8 | 2012 | 48 | |
| 9 | 2012 | 24 | |
| 10 | 2011 | 15 | |
| 11 | 2011 | 90 | |
| 12 | 2011 | 44 | |
| 13 | 2011 | 33 | |
| 14 | 2011 | 80 | |
| 15 | Abstract 15463: Pioglitazone Enhances Cholesterol Efflux From Macrophages by Increasing ABCA1/ABCG1 Expressions via LXR{alpha}/PPAR{gamma} Pathway: Findings From in vitro and ex vivo Studies | 2010 | 4 |
| 16 | 2010 | 16 | |
| 17 | 2009 | 90 | |
| 18 | 2009 | 39 | |
| 19 | Repairability of drug-induced "wavy ribs" in rat offspring. | 1982 | 44 |
About Maki Iizuka
Maki Iizuka is a scholar working on Anatomy, Biochemistry and Cancer Research, having authored 19 papers that have together received 744 indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (10 papers), Cancer, Lipids, and Metabolism (5 papers), Peroxisome Proliferator-Activated Receptors (5 papers), Drug Transport and Resistance Mechanisms (3 papers), Phytochemicals and Antioxidant Activities (3 papers), Antioxidant Activity and Oxidative Stress (3 papers), Lipoproteins and Cardiovascular Health (2 papers) and Blood Pressure and Hypertension Studies (2 papers). The work is most often cited by research in Biochemistry (123 citations), Endocrinology, Diabetes and Metabolism (157 citations) and Cancer Research (107 citations). Maki Iizuka has collaborated with scholars based in Japan and Norway. Frequent co-authors include Harumi Uto‐Kondo, Kazuo Kondo, Yoshimi Kishimoto, Tomohiro Komatsu, Katsunori Ikewaki, Makoto Ayaori, Shunichi Takiguchi, Mariko Tani, Emi Saita and Emi Yakushiji. Their work appears in journals such as Circulation, Stroke and Arteriosclerosis Thrombosis and Vascular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.